Latest Press Releases
More Press Releases
SimTrade Expands Multilingual Publishing to 26 Languages
SimTrade has expanded its website publishing capabilities to 26 languages, creating a broader multilingual foundation
Precore Gold Completes High-Resolution Magnetic Survey Beyond Arikepay’s Historical Drilling
128-km program targets concealed structures and potential extensions across the broader gold-copper system
Adeia Recognized with Two Asia Pacific Business Awards Honoring Regional Innovation and Leadership
Company named Asia Pacific Outstanding Company of the Year Steve Kim recognized as Outstanding Executive of the Year
Arbitflow Expands Professional Crypto Trading Access Through Managed Strategies
Arbitflow has expanded access to managed crypto trading through a platform built around professional traders and
New 2026 Insurance Exclusions and First-of-Its-Kind Federal Ruling Raise the Stakes for AI-Assisted Safety Investigations
Insurance carriers are moving to exclude AI-related claims from general liability coverage just as a federal court
Impauer Technologies Announces Launch Of New Corporate Website And Provides OTC Symbol Update
VANCOUVER, BC / ACCESS Newswire / September 16, 2026 / Impauer Technologies Inc. (CSE:IMPR) (the "Company" or
Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics
Transaction expected to create a Nasdaq-listed, multi-indication clinical-stage company focused on targeting neutrophil
Fenix Signed Athlete Jiaju Zhao Wins TOR330 & Breaks Course Record at Tor des Géants
In a landmark performance at the 2026 Tor des Géants, Fenix signed athlete Jiaju Zhao crossed the finish line first in
Greene Concepts Expands Beverage Manufacturing Visibility and Growth Opportunities Through Keychain CPG Platform
Company leverages premium Blue Ridge Mountain artesian water and its 60,000-square-foot manufacturing facility to
Tempo Therapeutics Closes Oversubscribed $14.5 Million Financing to Advance MAP(TM) Regenerative Technology
Financing follows FDA De Novo submission and publication of positive first-in-human clinical resultsCompany strengthens